BMGL Pursues $1B Bitcoin Acquisition Amid Surge
By ATTN Desk · Editorial oversight: Sean Han
BASEL MEDICAL GROUP LTD (NASDAQ: BMGL)
Introduction
BASEL MEDICAL GROUP LTD is a Singapore-based provider of orthopedic and trauma services, sports medicine and surgery, orthopedic procedures, and neurosurgical treatments. Incorporated in the British Virgin Islands in 2023, the company operates through Singapore-based subsidiaries and trades on the NASDAQ Capital Market under the ticker BMGL.
Corporate Structure and Experience
- Holding Company: British Virgin Islands
- Operating Subsidiaries: Based in Singapore (Gleneagles Medical Centre, 6 Napier Road, Units #02-10/11 and #03-07)
- Leadership Team:
- Dr. Darren Chhoa, Group Chief Executive Officer
- Kelvin Tan, Medical Director & Orthopaedic Specialist; Adjunct Assistant Professor, National University of Singapore
- Jessica Chen, Business Development
- Joseph Lua, Digital Marketing
- Clinical Team: Roster of orthopedic and neurosurgery specialists
- Client Network: Partnerships with over 20 insurance companies and more than 300 corporate clients, particularly in construction, marine, and oil and gas industries
- Operating History: Over 20 years of orthopedic and neurosurgical services in Singapore
Recent Developments and News
| Date | Event |
|---|---|
| 2025-02-25 | Trading commenced on NASDAQ Capital Market; IPO raised gross proceeds of US$10.143 million (including over-allotment of US$1.323 million). |
| 2025-04-30 | Completion of acquisition of Bethesda Medical Pte Ltd for total consideration of S$ 8 million. |
| 2025-05-16 | Announcement of exclusive negotiations for a US$ 1 billion Bitcoin acquisition via share-swap. |
| 2025-05-20 | Execution of a five-year Master Supply Agreement with Pancare Technology International (HK) Limited, up to AUD 450 million (~S$ 375 million) for healthcare products in Asia-Pacific. |
| 2025-05-22 | Form 6-K filing highlighting the Master Supply Agreement. |
Financial and Strategic Analysis
Stock Performance (as of 2025-05-30)
- Share Price: US$ 1.75
- Daily Change: +68.27%
- Volume: 9,413,937 shares
Key Metrics (TTM unless noted)
| Metric | Value |
|---|---|
| Market Capitalization | US$ 32.87 million (intraday) |
| Price/Earnings (P/E) | 19.44 |
| Earnings Per Share (EPS) | US$ 0.09 |
| Price/Sales | 2.46 |
| Price/Book | 3.33 |
| Enterprise Value/Revenue | 2.74 |
| Enterprise Value/EBITDA | 8.85 |
| Revenue | US$ 10.07 million |
| Net Income | US$ 2.07 million |
| Profit Margin | 20.58% |
| Return on Equity (ROE) | 31.77% |
| Return on Assets (ROA) | 8.44% |
| Total Cash | US$ 2.04 million |
| Total Debt/Equity | 75.55% |
| Levered Free Cash Flow | US$ 1.43 million |
Strategic Initiatives
- US$ 1 B Bitcoin Acquisition: A proposed share-swap to diversify treasury reserves and enhance capital structure.
- Master Supply Agreement: Long-term supply of medical products in Asia-Pacific, improving revenue stability.
- Mergers & Acquisitions: Completion of the acquisition of Bethesda Medical Pte Ltd and consideration of additional targets to expand services.
- Capital Deployment: IPO proceeds and over-allotment to be used for clinic expansion, technology upgrades, and working capital.
Market Position and Industry Context
- Sector: Private healthcare services—orthopedics and neurosurgery—operating primarily in Singapore and Southeast Asia
- Competitive Landscape:
- Public healthcare clusters: SingHealth, National Healthcare Group
- Private healthcare providers: Parkway Pantai, Raffles Medical Group
- Growth Drivers:
- Aging population (an estimated 25% of Singaporeans projected to be elderly by 2030)
- Increasing household incomes and private insurance coverage
- Demand for specialized musculoskeletal treatments
TL;DR
- On 2025-05-16, BMGL announced negotiations for a US$ 1 billion Bitcoin acquisition via a share-swap.
- On 2025-05-20, the company signed a five-year Master Supply Agreement valued up to AUD 450 million with Pancare Technology International.
- Share price increased 68.27% to US$ 1.75 on 2025-05-30, with trading volume at 9.4 million shares.
- Upcoming plans include finalizing the Bitcoin acquisition, integrating Bethesda Medical, and pursuing further investment opportunities to support regional expansion.